Pedro de Noronha Pissarra

Biotecnol Ltd. engages in research & development of immuno-oncology antibody products. It specializes in recombinant antibodies, T cell engaging, multispecific antibodies and oncology. The company is headquartered in London, the United Kingdom.

Chrysea Ltd. is an Irish company that focuses on changing the perception of aging. The company believes that the key factors in successful aging are non-smoking, moderate to high physical activity, and good social support. The company develops healthy-lifespan nutritional interventions that are backed by clinical research to improve naturally occurring anti-aging mechanisms. Pedro de Noronha Pissarra has been the CEO of the company since 2019.

Associação Nacional de Jovens Empresários provides enterprise development and business training for charity. It offers monitoring, advising, and mentoring. The company was founded in July 29, 1986 and is headquartered in Porto, Portugal.

Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.